PharmaCyte Biotech Inc (PMCB): We should be past the first 3-month test...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	2
Posts	239
Boards Moderated	0
Alias Born	03/23/2007

otto17

Re: None

Tuesday, 05/26/2020 9:17:49 AM

Tuesday, May 26, 2020 9:17:49 AM

We should be past the first 3-month test point already.

The tests for the Stability Study started approximately 3 months (the first time point in the 2-year study) from the issuance of the Certificate of Analysis for the second successful manufacturing run and will continue for 24 months. Data from the balance of the Stability Study will be provided to the FDA as the data becomes available.

Edit: Found it - this should put the 3-month point at May 12th (two weeks ago). So write it up! now!

February 12, 2020
LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has received the Certificates of Analysis and the records from both batches of its clinical trial product manufactured by Austrianova Singapore (Austrianova).